awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34110585-20CEBFF7-9DB6-4055-9C41-48D76122F49F
Q34110585-20CEBFF7-9DB6-4055-9C41-48D76122F49F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34110585-20CEBFF7-9DB6-4055-9C41-48D76122F49F
The RADAR study: week 48 safety and efficacy of RAltegravir combined with boosted DARunavir compared to tenofovir/emtricitabine combined with boosted darunavir in antiretroviral-naive patients. Impact on bone health
P2860
Q34110585-20CEBFF7-9DB6-4055-9C41-48D76122F49F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34110585-20CEBFF7-9DB6-4055-9C41-48D76122F49F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
52811e94345858253ca0b76e9e402d34146e09c7
P2860
Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.